Skip to content

Clinical trials

Phase 3 Cognitive Dysfunction trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 3 Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20111
20131
20143
20161
20171
20191
20211
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting3
Recruiting3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Hoffmann-La Roche2
Assistance Publique - Hôpitaux de Paris1
Eisai Co., Ltd.1
Eisai Inc.1
Groupe Hospitalier Pitie-Salpetriere1
Ipsen1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
TauRx Therapeutics Ltd1
University Hospital, Bordeaux1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction14
Alzheimer Disease11
Dementia5
Neurodegenerative Diseases2
Brain Diseases1
Consciousness Disorders1
Frontotemporal Dementia1
Lewy Body Disease1
Memory Disorders1
Mental Disorders1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.